10/22/2014 - 3:16pm

The pharmaceutical industry has committed considerable resources to developing both vaccines and treatments to address the current Ebola crisis.

 

10/22/2014 - 12:20pm

Pfizer last week announced that the Food and Drug Administration approved a revised label for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release capsules, for oral use, CII, to include abuse-deterrence studies. 

 

10/22/2014 - 9:47am

Adult millennials ages 18 years to 32 years worry about their health and access to health care as much as their baby boomer elders.

10/21/2014 - 12:35pm

Boehringer Ingelheim Pharmaceuticals on Monday announced that Ofev (nintedanib) capsules are now available in the United States. Ofev was approved by the Food and Drug Administration on Oct. 15 to treat idiopathic pulmonary fibrosis.

10/21/2014 - 9:49am

A team of scientists, led by researchers at the Wistar Institute, has identified a possible explanation for why middle-aged adults were hit especially hard by the H1N1 influenza virus during the 2013-14 influenza season.

 

10/21/2014 - 8:47am

McKesson and Health Mart on Monday featured solutions designed to help community pharmacies deliver better patient care and sustain growth.

 

10/21/2014 - 8:30am

H.D. Smith on Monday appointed Rob Meriweather as VP sales.

 

10/20/2014 - 10:22am

Cardinal Health on Monday announced that independent pharmacies can now take advantage of opportunities to co-brand with the Medicine Shoppe and Medicap Pharmacy franchising systems.

10/17/2014 - 4:09pm

Purdue Pharma has launched an awareness campaign to address specific knowledge gaps among pharmacists related to its Schedule III extended-release transdermal opioid, Butrans.